[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO982712L - Methods and intermediates for the preparation of 1-benzyl-4 - ((5,6-dimethoxy-1-indanone) -2-yl) methylpiperidine - Google Patents

Methods and intermediates for the preparation of 1-benzyl-4 - ((5,6-dimethoxy-1-indanone) -2-yl) methylpiperidine

Info

Publication number
NO982712L
NO982712L NO982712A NO982712A NO982712L NO 982712 L NO982712 L NO 982712L NO 982712 A NO982712 A NO 982712A NO 982712 A NO982712 A NO 982712A NO 982712 L NO982712 L NO 982712L
Authority
NO
Norway
Prior art keywords
alkyl
compound
formula
trifluoromethyl
alkoxy
Prior art date
Application number
NO982712A
Other languages
Norwegian (no)
Other versions
NO982712D0 (en
Inventor
Keith M Devries
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO982712L publication Critical patent/NO982712L/en
Publication of NO982712D0 publication Critical patent/NO982712D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår en fremgangsmåte for fremstilling av en forbindelse med formel l hvor R1 er R2O(C=0)- eller R3(C=O)-, R2 er (C,-C4)alkyl og R' er (C,-C4) alkyl eller fenyl, eventuelt substituert med fra en til tre substituenter uavhengig av hverandre valgt fra (C^C^alkyl, (C^C^alkoksy, halogen eller trifluormetyl, omfattende a) omsetning av en forbindelse med formel III hvor R1 er R2O(C=O)- eller R3(C=O)-, R2 er (C^COalkyl og Rs er (C,-C,) alkyl eller fenyl, eventuelt substituert med fra en til tre substituenter uavhengig av hverandre valgt fra (C,-C,)alkyl, (C,-C4)alkoksy, halogen eller trifluormetyl med et metenyleringsmiddel for fremstilling av en forbindelse med formel II hvor R' er R2O(C=O)- eller R3(C=0)-, R2 er (C,-CJalkyl og R3 er (C,-C4) alkyl eller fenyl, eventuelt substituert med fra en til tre substituenter uavhengig av hverandre valgt fra (C,-C<)alkyl, (C,-C4)alkoksy, halogen eller trifluormetyl og; b) omsetning av nevnte forbindelse med formel II med en sterk syre. Oppfinnelsen innbefatter videre et ytterligere trinn hvor forbindelsen med formel l reageres med hydroksyd for fremstilling av en forbindelse med formel VI, og omsetning av nevnte således dannede forbindelse med formel VI med et benzylhalogenid og en base for fremstilling av en forbindelse med formel VII. Foreliggende oppfinnelse angår også de nye mellomproduktene med formlene (l), (11) og (III).The present invention relates to a process for preparing a compound of formula I wherein R 1 is R 2 O (C = O) - or R 3 (C = O) -, R 2 is (C 1 -C 4) alkyl and R 1 is (C 1 -C 4 ) alkyl or phenyl, optionally substituted with from one to three substituents independently selected from (C 1 -C 4 alkyl, (C 1 -C 3 alkoxy, halogen or trifluoromethyl, comprising a) reacting a compound of formula III wherein R 1 is R 2 (C = O) - or R3 (C = O) -, R 2 is (C 1 -C 4 alkyl and R 5 is (C 1 -C 2) alkyl or phenyl, optionally substituted with from one to three substituents independently selected from (C , -C1) alkyl, (C1-C4) alkoxy, halogen or trifluoromethyl with a methenylating agent to prepare a compound of formula II wherein R 'is R2O (C = O) - or R3 (C = O) -, R2 is (C 1 -C 4 alkyl and R 3 is (C 1 -C 4) alkyl or phenyl, optionally substituted with from one to three substituents independently selected from (C 1 -C 4) alkyl, (C 1 -C 4) alkoxy, halogen or trifluoromethyl and; b) reacting said compound of formula II with a s dry acid. The invention further includes a further step wherein the compound of formula I is reacted with hydroxide to prepare a compound of formula VI, and reacting said compound of formula VI thus formed with a benzyl halide and a base for preparing a compound of formula VII. The present invention also relates to the novel intermediates of formulas (1), (11) and (III).

NO982712A 1995-12-15 1998-06-12 Methods and intermediates for the preparation of 1-benzyl-4 - ((5,6-dimethoxy-1-indanone) -2-yl) methylpiperidine NO982712D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US875395P 1995-12-15 1995-12-15
PCT/IB1996/001076 WO1997022584A1 (en) 1995-12-15 1996-10-11 Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine

Publications (2)

Publication Number Publication Date
NO982712L true NO982712L (en) 1998-06-12
NO982712D0 NO982712D0 (en) 1998-06-12

Family

ID=21733469

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982712A NO982712D0 (en) 1995-12-15 1998-06-12 Methods and intermediates for the preparation of 1-benzyl-4 - ((5,6-dimethoxy-1-indanone) -2-yl) methylpiperidine

Country Status (33)

Country Link
EP (1) EP0883607A1 (en)
JP (1) JP3066083B2 (en)
KR (1) KR20000064387A (en)
AP (1) AP708A (en)
AR (1) AR004368A1 (en)
AU (1) AU716462B2 (en)
BG (1) BG102525A (en)
BR (1) BR9612018A (en)
CA (1) CA2237647A1 (en)
CO (1) CO4750831A1 (en)
CZ (1) CZ180898A3 (en)
DZ (1) DZ2141A1 (en)
GT (1) GT199600092A (en)
HN (1) HN1996000065A (en)
HR (1) HRP960592A2 (en)
HU (1) HUP9904275A3 (en)
IL (3) IL124452A0 (en)
IS (1) IS4752A (en)
MA (1) MA24032A1 (en)
NO (1) NO982712D0 (en)
NZ (1) NZ318843A (en)
OA (1) OA10694A (en)
PE (1) PE25698A1 (en)
PL (1) PL197306B1 (en)
RO (1) RO121382B1 (en)
RU (1) RU2160731C2 (en)
SK (1) SK75498A3 (en)
TN (1) TNSN96153A1 (en)
TW (1) TW414787B (en)
UY (1) UY24401A1 (en)
WO (1) WO1997022584A1 (en)
YU (1) YU49486B (en)
ZA (1) ZA9610533B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE292116T1 (en) 1998-01-16 2005-04-15 Eisai Co Ltd METHOD FOR PRODUCING DONEPEZIL DERIVATIVES
IL125809A (en) 1998-08-17 2005-08-31 Finetech Lab Ltd Process and intermediates for production of donepezil and related compounds
US7148354B2 (en) * 2002-07-24 2006-12-12 Dr. Reddy's Laboratories Limited Process for preparation of donepezil
IL150982A (en) 2002-07-30 2007-02-11 Ori Lerman Process for the preparation of donepezil
IL151253A0 (en) * 2002-08-14 2003-04-10 Finetech Lab Ltd Process for production of highly pure donepezil hydrochloride
US6649765B1 (en) 2003-02-12 2003-11-18 Usv Limited, Bsd Marg. Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)
US6953856B2 (en) 2003-02-12 2005-10-11 Usv, Limited Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
US20070129549A1 (en) * 2003-03-21 2007-06-07 Yatendra Kumar Stable lamotrigine pharmaceutical compositions and processes for their preparation
WO2004099142A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Hydrobromide salt of benzyl-piperidylmethyl-indanone and its polymorphs
EP1654230A1 (en) 2003-07-01 2006-05-10 Hetero Drugs Limited Preparation of intermediates for acetyl cholinesterase inhibitors
CN1280273C (en) 2003-11-05 2006-10-18 天津和美生物技术有限公司 Synthesis of donepizin and its derivative
IL171137A (en) 2004-09-29 2012-01-31 Chemagis Ltd Process for preparing pharmaceutically pure amorphous donepezil hydrochloride by using purified donepezil maleate
CN100436416C (en) * 2005-07-29 2008-11-26 西南合成制药股份有限公司 Novel donepezil synthesis process
GB0515803D0 (en) * 2005-07-30 2005-09-07 Pliva Hrvatska D O O Intermediate compounds
AR057910A1 (en) 2005-11-18 2007-12-26 Synthon Bv PROCESS TO PREPARE DONEPEZILO
ES2354737T3 (en) * 2006-01-04 2011-03-17 Cipla Limited PROCEDURE AND INTERMEDIATE PRODUCT FOR THE PREPARATION OF DONEPEZYLO.
CA2672212A1 (en) 2006-12-11 2008-06-19 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
WO2013078608A1 (en) * 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same
WO2015022418A1 (en) 2013-08-16 2015-02-19 Takeda Gmbh Treatment of cognitive impairment with pde4 inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (en) * 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt
FR2642069B1 (en) * 1989-01-20 1991-04-12 Rhone Poulenc Sante NOVEL BENZOPYRAN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE4439822A1 (en) * 1994-11-08 1996-08-29 Bayer Ag Process for the preparation of benzyl-piperidylmethyl-indanones

Also Published As

Publication number Publication date
YU49486B (en) 2006-08-17
TNSN96153A1 (en) 2005-03-15
AR004368A1 (en) 1998-11-04
HUP9904275A2 (en) 2000-05-28
UY24401A1 (en) 1997-06-09
EP0883607A1 (en) 1998-12-16
CA2237647A1 (en) 1997-06-26
HRP960592A2 (en) 1998-06-30
IS4752A (en) 1998-05-22
GT199600092A (en) 1998-05-12
RO121382B1 (en) 2007-04-30
BR9612018A (en) 1999-02-17
HN1996000065A (en) 1997-06-26
TW414787B (en) 2000-12-11
AP708A (en) 1998-12-04
HUP9904275A3 (en) 2001-05-28
MA24032A1 (en) 1997-07-01
ZA9610533B (en) 1998-06-15
PE25698A1 (en) 1998-05-21
AU7092596A (en) 1997-07-14
JP3066083B2 (en) 2000-07-17
PL327512A1 (en) 1998-12-21
YU66096A (en) 1999-11-22
KR20000064387A (en) 2000-11-06
AP9600892A0 (en) 1997-01-31
IL136421A0 (en) 2001-06-14
CZ180898A3 (en) 1999-05-12
SK75498A3 (en) 1999-08-06
CO4750831A1 (en) 1999-03-31
BG102525A (en) 1999-05-31
OA10694A (en) 2001-05-04
JPH11500756A (en) 1999-01-19
IL124452A0 (en) 1998-12-06
RU2160731C2 (en) 2000-12-20
MX9804820A (en) 1998-10-31
NO982712D0 (en) 1998-06-12
WO1997022584A1 (en) 1997-06-26
DZ2141A1 (en) 2002-07-23
PL197306B1 (en) 2008-03-31
NZ318843A (en) 2000-01-28
AU716462B2 (en) 2000-02-24
IL136420A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
NO982712L (en) Methods and intermediates for the preparation of 1-benzyl-4 - ((5,6-dimethoxy-1-indanone) -2-yl) methylpiperidine
EA200001135A1 (en) METHOD OF OBTAINING IZOXAZOLIN-3-IL-ACYLBENZENES
CA2161542A1 (en) Novel 5-Pyrrolyl-2-Pyridylmethylsulfinyl Benzimidazole Derivatives
NO20002490D0 (en) Process for the preparation of 1,4-dihydropyridines and compounds used in this process
DE60133288D1 (en) PROCESS FOR THE PREPARATION OF FEXOFENADINES
DE69922417D1 (en) PROCESS FOR PREPARING AMLODIPIN BENZENE SULPHONATE
BG60267B1 (en) METHOD FOR THE PREPARATION OF AMIDOXIM DERIVATIVES
ES474081A1 (en) Antipsychotic 1-(4,4-bis(4-fluorophenyl) butyl)-4-phenoxy-1,2,3,6-tetrahydropyridines
ES2016017A6 (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives.
HUP9800511A2 (en) Process for producing 4-{4-[4-(hydroxy-diphenyl)-1-piperidinyl]-1-hydroxy-butyl}-alpha-alpha-dimethyl-phenyl-acetic.acid and phosphorylized derivatives thereof
SU718011A3 (en) Method of producing phenylthieno-(2,3-c) piperidine derivatives or salts thereof
DE69725167D1 (en) N-BENZOLSULFONYL-L-PROLIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR THERAPEUTIC USE
ATE30718T1 (en) PREPARATION OF 1-BENZYL AZETIDIN-3-OL AND THE CORRESPONDING HALID ACID.
DK571284D0 (en) INDEX DERIVATIVES, MEDICINE CONTAINING THESE DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION
NO901534L (en) PROCEDURE FOR THE PREPARATION OF GLUTARIC ACID DERIVATIVES.
NO20010801L (en) New 6-amino- or 6-hydroazino-sulfonyl-3-quinolynylphosphonic acid compound, process of their preparation and pharmaceutical compositions containing them
IE812500L (en) Piperidine derivatives
NO20000344D0 (en) Process for the preparation of 1,3-diaza-spiro (4,4) non-1-one-one derivatives and 1-cyano-1-acylamine cyclopentane intermediates
YU45942B (en) PROCESS FOR THE PREPARATION OF HYDROCHLORIDE 2 (N-BENZYL-N-METHYLAMINO) -ETHYL-METHYL-1,4-DIHYDRO-2,6-DIMETHYL-4- (3-NITROPHENYL) -3,5-PYRIDINE-DICARBOC SIL
DE3270999D1 (en) N-SUBSTITUTED TETRAHYDROISOPHTHALIMIDE DERIVATIVES
KR880000396A (en) Preparation of 2- (N-benzyl-N-methylamino) ethylmethyl 2,6-dimethyl-4- (m-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylate and its hydrochloride salt Way

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application